ArticleAntimicrobial resistance and infection control2026
Multidrug-resistant organism carriage in Vietnamese district hospitals before and after an antimicrobial stewardship intervention.
Article in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionAntimicrobial resistance is a critical global health challenge, with Southeast Asia identified as a hotspot of multidrug-resistant organism (MRO) carriage in hospitalised patients and the general population. This study aimed to estimate the prevalence of gastrointestinal and nasal MRO carriage among district hospital inpatients in Vietnam and assess changes following an antimicrobial stewardship (AMS) intervention.
methodsTwo repeated cross-sectional prevalence surveys were conducted among inpatients at four district hospitals in Vietnam (two urban hospitals in Hanoi and two rural hospitals in Ca Mau). The baseline survey was undertaken immediately prior to implementation of a 6-month AMS intervention (March 2022), and the post-intervention survey was conducted during the final 2 weeks of the intervention (August 2022). The intervention bundle comprised establishing hospital AMS committees and teams, implementing antimicrobial prescribing guidelines, healthcare worker education, and regular antimicrobial prescribing audits with feedback to clinicians. Carriage of extended spectrum β-lactamase (ESBL)-producing Enterobacterales and carbapenemase-producing Enterobacterales (CPE) was determined from stool or rectal swabs, and methicillin-resistant Staphylococcus aureus (MRSA) carriage using nasal swabs. MROs were characterised using phenotypic antimicrobial susceptibility testing and molecular analyses. A participant questionnaire assessed demographic, behavioural and healthcare-related risk factors. Pre- and post-intervention prevalence estimates were compared using two-proportion tests. Mixed-effects binary regression models were used to identify risk factors for ESBL-producing Enterobacterales carriage.
resultsA total of 402 participants (ages 18-99 years, M:F 176:226) provided nasal swabs and rectal or stool samples across both surveys. Participant demographics differed modestly between surveys. Overall, 76.1% of participants carried Enterobacterales isolates harbouring bla
conclusionESBL-producing Enterobacterales carriage was highly prevalent among inpatients in four Vietnamese district hospitals, while CPE and MRSA carriage remained low. A 6-month AMS intervention was associated with a modest reduction in MRSA carriage but no change in ESBL-producing Enterobacterales or CPE carriage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.